BioWorld Asia

Oct. 5, 2005

View Archived Issues

Scientists Probe Signature' Of Cancer Genetic Damage

Read More

NatImmune, Enzon Enter Deal On Recombinant MBL

Read More

Closing In On First Revenues, Phoqus Seeking IPO On Aim

Read More

MMI Raises £10M For Genvax's Clinical Studies Of Vaccines

Read More

Other News To Note

Read More

Karo Bio Seeking SEK280M In Discounted Rights Issue

Karo Bio AB is seeking SEK280 million (US$35.9 million) in a discounted rights issue to fund its switch from early stage discovery to clinical development. (BioWorld International) Read More

SkyePharma Raising Funds After Scuttled Partner Deal

Read More